XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.0.1
SHARE-BASED COMPENSATION (Tables)
3 Months Ended
Jan. 28, 2024
SHARE-BASED COMPENSATION [Abstract]  
Share-based Compensation Expenses The table below presents information on our share-based compensation expenses for the three-month periods ended January 28, 2024, and January 29, 2023.


    Three Months Ended  
   
January 28,
2024
   
January 29,
2023
 
Expense reported in:
           
Cost of goods sold
 
$
595
   
$
281
 
Selling, general, and administrative
   
1,749
     
1,378
 
Research and development
   
229
     
162
 
Total expense incurred
 
$
2,573
   
$
1,821
 
                 
Expense by award type:
               
Restricted stock awards
 
$
2,573
   
$
1,764
 
Stock options
   
-
     
1
 
Employee stock purchase plan
   
-
     
56
 
Total expense incurred
 
$
2,573
   
$
1,821
 
                 
Income tax benefits of share-based compensation
 
$
99
   
$
155
 
Share-based compensation cost capitalized
 
$
-
   
$
-
 
Restricted Stock Awards Activity The table below presents information on our restricted stock awards for the three-month periods ended January 28, 2024, and January 29, 2023.


   
Three Months Ended
 
   
January 28,
2024
   
January 29,
2023
 
Number of shares granted in period
   
825,050
     
786,500
 
Weighted-average grant-date fair value of awards (in dollars per share)
 
$
29.77
   
$
16.77
 
Compensation cost not yet recognized
 
$
31,426
   
$
18,526
 
Weighted-average amortization period for cost not yet recognized (in years)
   
3.3
     
3.2
 
Shares outstanding at balance sheet date
   
1,634,315
     
1,374,422
 
Stock Options Activity The table below presents information on our stock options for the three-month periods ended January 28, 2024, and January 29, 2023.


   
Three Months Ended
 
   
January 28,
2024
   
January 29,
2023
 
Number of options granted in period
   
-
     
-
 
Cash received from options exercised
 
$
936
   
$
563
 
Compensation cost not yet recognized
 
$
-
   
$
-
 
Weighted-average amortization period for cost not yet recognized (in years)
   
-
     
-
 
Information on Outstanding and Exercisable Option

Information on outstanding and exercisable option awards as of January 28, 2024, is presented below.

Options
 
Shares
   
Weighted-
Average
Exercise
Price
   
Weighted-
Average
Remaining
Contractual
Life (in years)
   
Aggregate
Intrinsic
Value
 
Outstanding and exercisable at January 28, 2024
   
375,525
   
$
10.31
   

2.59
   
$
7,448